Immune Reconstitution

$154,483ZIAFY2012AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Linked publications & trials

Paper 35797339 Paper 35447072 Paper 35378757 Paper 35361968 Paper 35174859 Paper 35062015 Paper 34921774 Paper 34417590 Paper 34400835 Paper 34369597 Paper 34366247 Paper 34315825 Paper 34310620 Paper 34237254 Paper 34233096 Paper 34210892 Paper 34159328 Paper 34075385 Paper 34075375 Paper 34038789 Paper 34013272 Paper 33971664 Paper 33907752 Paper 33903232 Paper 33823129 Paper 33766885 Paper 33732238 Paper 33720905 Paper 33717194 Paper 33688652 Paper 33655252 Paper 33619494 Paper 33351785 Paper 33214287 Paper 32895550 Paper 31308541 Paper 31192893 Paper 30958799 Paper 30320604 Paper 30142226 Paper 29781814 Paper 29664020 Paper 29401318 Paper 23607606 Paper 22236196 Paper 22133778 Paper 21734237 Paper 21726511 Paper 21593401 Paper 21555857 Paper 21501617 Paper 21421838 Paper 21398582 Paper 21383244 Paper 21301479 Paper 21270159 Paper 21252259 Paper 21215812 Paper 21198661 Paper 21164527 Paper 21135165 Paper 21097671 Paper 20980630 Paper 20974936 Paper 20961439 Paper 20887220 Paper 20844049 Paper 20808901 Paper 20620940 Paper 20610726 Paper 20565257 Paper 20543597 Paper 20489056 Paper 20484731 Paper 20484518 Paper 20468055 Paper 20432235 Paper 20375158 Paper 20208540 Paper 19941883 Paper 19828697 Paper 19776383 Paper 17505014 Paper 17464756 Paper 16728284 Paper 15920008 Paper 15738052 Paper 15531581 Paper 12956764 Paper 12688355 Paper 12411295 Paper 11830500 Paper 11593319

Abstract

In patients treated with chemotherapy and bone marrow transplantation for leukemia, there are variable rates of reconstitution of T cell numbers and function. An understanding of the mechanisms underlying the recovery of T cells will be important for the design of future strategies to improve T cell reconstitution. The thymus is the organ responsible for producing new naive T cells with a broad immune repertoire from bone marrow-derived precursors. This study examines the role of the thymus in immune reconstitution and how it is affected by immunosuppression and graft-versus-host disease. We also pursue the same therapeutic goals in HIV-infected individuals aiming to improve immune reconstitution.

View original record on NIH RePORTER →